Syros Pharmaceuticals, Inc.
OTC: SYRS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- James E. Bradner
- Employees
- 68
- Headquarters
- Cambridge, United States
- IPO year
- 2016
- Market cap
- $2.7K
- Website
- https://www.syros.com
Loading SYRS…
Loading profile data…Frequently asked questions about SYRS
What does Syros Pharmaceuticals, Inc. (SYRS) do?
Syros Pharmaceuticals, Inc. operates as a biopharmaceutical firm primarily focused on discovering and developing novel therapeutic solutions for various cancers and monogenic (single-gene) diseases. A key strategic aim for the company involves cultivating a robust pipeline of medicines that modulate gene expression. Its leading investigational d...
Where does SYRS trade?
Syros Pharmaceuticals, Inc. (SYRS) trades on the Other OTC.
What sector is SYRS in?
Syros Pharmaceuticals, Inc. (SYRS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Syros Pharmaceuticals, Inc.?
James E. Bradner is the chief executive officer of Syros Pharmaceuticals, Inc. (SYRS).
Where is Syros Pharmaceuticals, Inc. headquartered?
Syros Pharmaceuticals, Inc. is headquartered in United States.
Does SYRS pay a dividend?
Syros Pharmaceuticals, Inc. (SYRS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SYRS go public?
Syros Pharmaceuticals, Inc. (SYRS) completed its initial public offering in 2016.